Predictions
Dexcom Inc.
Start price
Target price
Perf. (%)
€57.00
11.02.20
11.02.20
€78.75
04.11.21
04.11.21
137.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€9.10
01.02.20
01.02.20
€12.00
01.10.20
01.10.20
-6.04%
01.10.20
01.10.20
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€50.50
28.01.20
28.01.20
€55.00
04.11.21
04.11.21
-23.09%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Astrazeneca ADR
Start price
Target price
Perf. (%)
€45.60
19.01.20
19.01.20
€55.00
04.11.21
04.11.21
21.49%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€127.44
17.01.20
17.01.20
€160.00
04.11.21
04.11.21
83.69%
05.11.21
05.11.21
Codexis Inc.
Start price
Target price
Perf. (%)
€16.50
12.01.20
12.01.20
-
04.11.21
04.11.21
114.55%
05.11.21
05.11.21
Probably not worthwhile Investment
Gensight Biologics SA
Start price
Target price
Perf. (%)
€4.07
12.01.20
12.01.20
€8.50
04.11.21
04.11.21
35.92%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Repligen Corp.
Start price
Target price
Perf. (%)
€87.50
12.01.20
12.01.20
€155.00
04.11.21
04.11.21
170.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.44
06.01.20
06.01.20
-
09.01.20
09.01.20
1.35%
09.01.20
09.01.20
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€2.80
04.01.20
04.01.20
-
04.11.21
04.11.21
112.50%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.38
20.12.19
20.12.19
€86.00
23.04.20
23.04.20
21.40%
23.04.20
23.04.20
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.46
17.12.19
17.12.19
€6.00
04.11.21
04.11.21
103.76%
05.11.21
05.11.21
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
10.12.19
10.12.19
€13.00
04.11.21
04.11.21
20.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€104.80
08.12.19
08.12.19
€125.00
31.01.20
31.01.20
3.63%
31.01.20
31.01.20
Abiomed Inc.
Start price
Target price
Perf. (%)
€177.80
01.12.19
01.12.19
€300.00
04.11.21
04.11.21
49.94%
29.04.21
29.04.21
Could be worthwhile Investment >10% per year
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€9.50
27.11.19
27.11.19
€25.00
04.11.21
04.11.21
-16.00%
05.11.21
05.11.21
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€109.44
27.11.19
27.11.19
-
04.11.21
04.11.21
65.25%
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Aphria Inc.
Start price
Target price
Perf. (%)
€4.29
25.11.19
25.11.19
-
04.11.21
04.11.21
196.12%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model